Docosahexaenoic acid prevents trans-10, cis-12-conjugated linoleic acid-induced nonalcoholic fatty liver disease in mice by altering expression of hepatic genes regulating fatty acid synthesis and oxidation

Metabolic Syndrome and Related Disorders

Volumn 10, Issue 3, 2012, Pages 175-180

  Fedor, Dawn M ^a   Adkins, Yuriko ^a   MacKey, Bruce E ^b   Kelley, Darshan S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b WESTERN REGIONAL RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOCOSAHEXAENOIC ACID; FATTY ACID; GLUCOSE; INSULIN; LINOLEIC ACID; RNA; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FATTY ACID OXIDATION; FATTY ACID SYNTHESIS; FEMALE; GENE EXPRESSION REGULATION; GLUCOSE BLOOD LEVEL; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MOUSE; NONALCOHOLIC FATTY LIVER; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION;

ADIPOSITY; ANIMALS; BLOOD GLUCOSE; DISEASE MODELS, ANIMAL; DOCOSAHEXAENOIC ACIDS; FATTY LIVER; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; INSULIN; INSULIN RESISTANCE; LINOLEIC ACIDS, CONJUGATED; LIPID METABOLISM; LIVER; MICE; MICE, INBRED C57BL; OXIDATION-REDUCTION; TIME FACTORS; TRIGLYCERIDES;

EID: 84861739927     PISSN: 15404196     EISSN: 15578518     Source Type: Journal    
DOI: 10.1089/met.2011.0113     Document Type: Article

References (41)

1. Musso G, Gambino R, Cassader M. Recent insights into hepatic lipid metabolism in non-Alcoholic fatty liver disease (NAFLD). Prog Lipid Res 2009;48:1-26.
2. Byrne CD. Fatty liver: Role of inflammation and fatty acid nutrition. Prostaglandins Leukot Essent Fatty Acids 2010;82: 265-271.
3. CohenJC, Horton JD,HobbsHH.Human fatty liver disease: Old questions and new insights. Science 2011;332:1519-1523.
4. Masterton GS, Plevris JN, Hayes PC. Review article: Omega-3 fatty acids-A promising novel therapy for non-Alcoholic fatty liver disease. Aliment Pharmacol Ther 2010;31:679-692.
5. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002;346:1221-1231.
6. Kim HJ, Lee KE, Kim DJ, et al. Metabolic significance of nonalcoholic fatty liver disease in nonobese, nondiabetic adults. Arch Intern Med 2004;164:2169-2175.
7. Cowie CC, Rust KF, Ford ES, et al. Full accounting of diabetes and pre-diabetes in the US population in 1988-1994 and 2005-2006. Diabetes Care 2009;32:287-294.
8. Vyas D, Kadegowda AK, Erdman RA. Dietary conjugated linoleic acid and hepatic steatosis: Species-specific effects on liver and adipose lipid metabolism and gene expression. J Nutr Metab 2012;ID 932928; doi:10.1155/2012/932928.
9. El-Badry AM, Graf R, Clavien PA. Omega 3-Omega 6: What is right for the liver? J Hepatol 2007;47:718-725. (Pubitemid 47503438)
10. Kien CL. Dietary interventions for metabolic syndrome: Role of modifying dietary fats. Curr Diab Rep 2009;9:43-50.
11. Micha R, Mozaffarian D. Trans fatty acids: Effects on metabolic syndrome, heart disease and diabetes. Nat Rev Endocrinol 2009;5:335-344.
12. Spadaro L, Magliocco O, Spampinato D, et al. Effects of n-3 polyunsaturated fatty acids in subjects with nonalcoholic fatty liver disease. Dig Liver Dis 2008;40:194-199. (Pubitemid 351181793)
13. Tanaka N, Sano K, Horiuchi A, et al. Highly purified eicosapentaenoic acid treatment improves nonalcoholic steatohepatitis. J Clin Gastroenterol 2008;42:413-418. (Pubitemid 351450629)
14. Teegala SM, Willett WC, Mozaffarian D. Consumption and health effects of trans fatty acids: A review. J AOAC Int 2009;92:1250-1257.
15. Vega GL, Chandalia M, Szczepaniak LS, et al. Effects of N-3 fatty acids on hepatic triglyceride content in humans. J Investig Med 2008;56:780-785.
16. Kelley DS, Erickson KL. Modulation of body composition and immune cell functions by conjugated linoleic acid in humans and animal models: Benefits vs. risks. Lipids 2003;38:377-386. (Pubitemid 36724294)
17. Flachs P, Mohamed-Ali V, Horakova O, et al. Polyunsaturated fatty acids of marine origin induce adiponectin in mice fed a high-fat diet. Diabetologia 2006;49:394-397. (Pubitemid 43185410)
18. Le Foll C, Corporeau C, Le Guen V, et al. Long-chain n-3 polyunsaturated fatty acids dissociate phosphorylation of Akt from phosphatidylinositol 3¢-kinase activity in rats. Am J Physiol Endocrinol Metab 2007;292:E1223-E1230. (Pubitemid 46536524)
19. Alwayn IP, Gura K, Nose V, et al. Omega-3 fatty acid supplementation prevents hepatic steatosis in a murine model of nonalcoholic fatty liver disease. Pediatr Res 2005;57: 445-452. (Pubitemid 40293615)
20. Ghafoorunissa, IA, Rajkumar L, Acharya V. Dietary (n-3) long chain polyunsaturated fatty acids prevent sucroseinduced insulin resistance in rats. J Nutr 2005;135:2634-2638. (Pubitemid 43156606)
21. Rossi AS, Lombardo YB, Lacorte JM, et al. Dietary fish oil positively regulates plasma leptin and adiponectin levels in sucrose-fed, insulin-resistant rats. Am J Physiol Regul Integr Comp Physiol 2005;289:R486-R494. (Pubitemid 41060504)
22. Gonzalez-Periz A, Horrillo R, Ferre N, et al. Obesity-induced insulin resistance and hepatic steatosis are alleviated by omega-3 fatty acids: A role for resolvins and protectins. FASEB J 2009;23:1946-1957.
23. Ide T. Interaction of fish oil and conjugated linoleic acid in affecting hepatic activity of lipogenic enzymes and gene expression in liver and adipose tissue. Diabetes 2005;54:412-423.
24. Winzell MS, Pacini G, Ahren B. Insulin secretion after dietary supplementation with conjugated linoleic acids and n-3 polyunsaturated fatty acids in normal and insulin-resistant mice. Am J Physiol Endocrinol Metab 2006;290:E347-E354.
25. Yanagita T, Wang YM, Nagao K, et al. Conjugated linoleic acid-induced fatty liver can be attenuated by combination with docosahexaenoic acid in C57BL/6N mice. J Agric Food Chem 2005;53:9629-9633. (Pubitemid 41784175)
26. Vemuri M, Kelley DS, Mackey BE, et al. Docosahexaenoic acid (DHA) but not eicosapentaenoic acid (EPA) prevents trans-10, cis-12 conjugated linoleic acid (CLA)-induced insulin resistance in mice. Metab Syndr Relat Disord 2007;5:315-322. (Pubitemid 350208895)
27. Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care 2004;27:1487-1495. (Pubitemid 38680001)
28. Folch J, Lees M, Sloane Stanley GH. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 1957;226:497-509.
29. Box G, Hunger, WG and Hunter, JS. Statistics for Experimenters: An Introduction to Design, Data Analysis, and Model Building. New York: Wiley, 1978.
30. Kelley DS, Bartolini GL, Warren JM, et al. Contrasting effects of t10,c12- and c9,t11-conjugated linoleic acid isomers on the fatty acid profiles of mouse liver lipids. Lipids 2004; 39:135-141. (Pubitemid 38480943)
31. Kelley DS, Vemuri M, Adkins Y, et al. Flaxseed oil prevents trans-10, cis-12-conjugated linoleic acid-induced insulin resistance in mice. Br J Nutr 2009;101:701-708.
32. Neff LM, Culiner J, Cunningham-Rundles S, et al. Algal docosahexaenoic acid affects plasma lipoprotein particle size distribution in overweight and obese adults. J Nutr 2011;141: 207-213.
33. Nobili V, Bedogni G, Alisi A, et al. Docosahexaenoic acid supplementation decreases liver fat content in children with non-Alcoholic fatty liver disease: Double-blind randomised controlled clinical trial. Arch Dis Child 2011;96:350-353.
34. Kelley DS, Adkins Y, Woodhouse LR, et al. Docosahexaenoic acid supplementation improved lipocentric but not glucocentric markers of insulin sensitivity in hypertriglyceridemic men. Metab Syndr Relat Disord (in press).
35. Wendel AA, Purushotham A, Liu LF, et al. Conjugated linoleic acid induces uncoupling protein 1 in white adipose tissue of ob/ob mice. Lipids 2009;44:975-982.
36. Rasooly R, Kelley DS, Greg J, et al. Dietary trans 10, cis 12-conjugated linoleic acid reduces the expression of fatty acid oxidation and drug detoxification enzymes in mouse liver. Br J Nutr 2007;97:58-66. (Pubitemid 46662059)
37. Takahashi Y, Kushiro M, Shinohara K, et al. Activity and mRNA levels of enzymes involved in hepatic fatty acid synthesis and oxidation in mice fed conjugated linoleic acid. Biochim Biophys Acta 2003;1631:265-273. (Pubitemid 36369362)
38. Warren JM, Simon VA, Bartolini G, et al. Trans-10,cis-12 CLA increases liver and decreases adipose tissue lipids in mice: Possible roles of specific lipid metabolism genes. Lipids 2003;38:497-504. (Pubitemid 36760236)
39. Degrace P, Demizieux L, Gresti J, et al. Hepatic steatosis is not due to impaired fatty acid oxidation capacities in C57BL/6J mice fed the conjugated trans-10,cis-12-isomer of linoleic acid. J Nutr 2004;134:861-867. (Pubitemid 38456255)
40. Kelley DS, Siegel D, Vemuri M, et al. Docosahexaenoic acid supplementation improves fasting and postprandial lipid profiles in hypertriglyceridemic men. Am J Clin Nutr 2007;86: 324-333. (Pubitemid 47256914)
41. Park Y, Harris WS. Omega-3 fatty acid supplementation accelerates chylomicron triglyceride clearance. J Lipid Res 2003;44:455-463. (Pubitemid 37279692)